临床超声造影剂的特征与回声特性:体外与体内比较研究
该研究对比了SonoVue、Definity和Optison三种超声造影剂的理化特征及体外体内超声造影成像性能。体外和体内结果均显示SonoVue性能与Definity相似或更优,但优于Optison;在猪心脏中SonoVue增强持续时间长于Definity,定量分析显示SonoVue增强高1.5倍。
要点
- SonoVue的归一化散射功率较Optison高2至10倍,体外性能优于Optison。
- 猪心脏造影中SonoVue增强持续时间长于Definity,定量增强高1.5倍。
- 肝脏造影中SonoVue与Definity增强及持续时间相似,但两者均优于Optison。
核心结论
- 在本研究条件下,SonoVue成像性能与Definity相似或略优,但优于Optison。
研究设计与样本
- 体外与体内对比研究,使用3种市售超声造影剂,采用Multisizer Coulter Counter测量理化特征,两种超声系统及不同探头进行体外剂量递增测量,并在猪(心脏和肝脏)和兔(肝脏)进行体内成像比较,定量分析使用VueBox软件。
关键影像表现/征象
- 体外测量理化特征与厂商提供数据一致。
- 体外数据示SonoVue性能与Definity相似或更优,但优于Optison,SonoVue归一化散射功率高2至10倍。
- 体内结果类似,但猪心脏中SonoVue增强持续时间长于Definity,定量分析显示SonoVue增强高1.5倍。
- 肝脏成像中SonoVue与Definity增强及持续时间相似,但两者峰值增强和持续时间均优于Optison,SonoVue较Optison增高至多2倍。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To compare physicochemical characteristics and in vitro and in vivo contrast-enhanced ultrasound imaging performance of 3 commercially available ultrasound contrast agents: SonoVue (Bracco Imaging SpA, Colleretto Giacosa, Italy; also marketed as Lumason in the USA), Definity (Lantheus Medical Imaging, North Billerica, MA) and Optison (GE Healthcare AS, Oslo, Norway).
METHODS: Physicochemical characteristics were measured with a Multisizer Coulter Counter (Beckman Coulter, Fullerton, CA). Two ultrasound systems (Aplio 500; Toshiba Medical Systems Corp, Tochigi-ken, Japan; and Logiq E9; GE Healthcare, Little Chalfont, England) were used with different transducers. Contrast enhancement was measured in vitro by dose-ranging measurements using a custom-built beaker setup; in vivo imaging performances were compared in pigs (heart and liver) and rabbits (liver). Quantitative analyses were performed with VueBox quantification software (Bracco Suisse SA, Plan-les-Ouates, Switzerland).
RESULTS: Measured physicochemical characteristics were in agreement with those provided by the manufacturers. In vitro data demonstrated that the performance of SonoVue was similar to or better than that of Definity but superior to Optison (normalized scattered power 2- to 10-fold higher with SonoVue). Similar results were obtained in vivo, although the duration of enhancement in the pig heart was longer for SonoVue compared to Definity, and quantitative analysis revealed higher enhancement for SonoVue (1.5-fold increase). For liver imaging, SonoVue and Definity showed similar contrast enhancement and duration of enhancement, but compared to Optison, both peak enhancement and duration of enhancement were superior for SonoVue (up to 2-fold increase).
CONCLUSIONS: Imaging performance of SonoVue was similar to or slightly better than that of Definity, but it was superior to Optison for the conditions used in this study.
引用
- Hyvelin JM, Gaud E, Costa M, et al. Characteristics and Echogenicity of Clinical Ultrasound Contrast Agents: An In Vitro and In Vivo Comparison Study. J Ultrasound Med. 2017. PMID: 28240842. doi:10.7863/ultra.16.04059
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。